Determinants of In-Stent Restenosis after Carotid Angioplasty: A Case-Control Study

Abstract

Purpose:

To report a retrospective study that sought to identify clinical factors contributing to the development of in-stent restenosis in the carotid arteries, to profile the patients at greatest risk, and to review the treatment modalities evolved from our experience.

Methods:

Between December 2000 and April 2003, 195 carotid angioplasty/stenting (CAS) procedures (12 bilateral) were performed in 183 patients (131 men; median age 65.9 years, interquartile range 55.2–72.7). Stenting for de novo stenoses was performed in 119 (61%) carotid arteries; 76 (39%) vessels were treated for postsurgical restenosis. Nearly two thirds of the patients (117, 64%) were symptomatic. Patients were evaluated at 3 and 6 months and at 6-month intervals thereafter with duplex ultrasonography. Angiography was used to confirm any recurrent lesion detected on the ultrasound scan.

Results:

Overall perioperative neurological complications included 4 (2.2%) minor strokes, 1 (0.5%) intracranial hemorrhage, and 1 (0.5%) major stroke; both patients with major neurological complications died at 5 and 12 days, respectively, after the procedure. During the 12.5-month follow-up (range 0–27.2), 3 non-procedure-related late deaths and another 9 (4.9%) neurological events occurred (2 strokes and 7 transient ischemic attacks).

In-stent restenosis after CAS was present in 10 (5.2%) of 193 carotid arteries (9/181 patients) in follow-up; all but 1 artery had been treated for postsurgical restenosis. All lesions were treated secondarily with endovascular procedures. Statistical analysis demonstrated that postsurgical restenosis was the only predictive factor for the development of in-stent restenosis (OR 15.5, 95% CI 2.05 to 125.6, p = 0.001) in this cohort.

Conclusions:

The present study, far from being exhaustive on the subject, indicates that patients who develop restenosis after carotid endarterectomy are also prone to develop restenosis after CAS; moreover, although strongly recommended for postsurgical restenosis, CAS carries a greater risk of in-stent restenosis in this subgroup, thus reducing the benefits of this procedure.

Keywords

carotid artery carotid stenosis angioplasty stent restenosis endarterectomy postsurgical restenosis in-stent restenosis stroke mortality outcome analysis

Get full access to this article

View all access options for this article.

References

Roubin

Yadav

Iyer

. Carotid stent-supported angioplasty: A neurovascular intervention to prevent stroke. Am J Cardiol. 1996; 78(Suppl 3A): 8–12.

Diethrich

Ndiaye

Reid

. Stenting in the carotid artery: Initial experience in 110 patients. J Endovasc Surg. 1996; 3: 42–62.

Yadav

Roubin

Iyer

. Elective stenting of the extracranial carotid arteries. Circulation. 1997; 95: 376–381.

Criado

Wellons

Clark

. Evolving indications for and early results of carotid artery stenting. Am J Surg. 1997; 174: 111–114.

Hobson

Goldstein

Jamil

. Carotid restenosis: Operative and endovascular management. J Vasc Surg. 1999; 29: 228–238.

Chakhtoura

Hobson

Goldstein

. In-stent restenosis after carotid angioplasty-stenting: Incidence and management. J Vasc Surg. 2001; 33: 220–226.

North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325: 445–453.

Zwiebel

. Doppler evaluation of carotid stenosis. In: Zwiebel

, ed. Introduction to Vascular Ultrasonography. 3rd ed. Philadelphia: WB Saunders; 1992: 123–132.

Gray-Weale

Graham

Burnett

. Carotid artery atheroma: Comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg. 1988; 29: 676–681.

10.

European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet. 1991; 337: 1235–1243.

11.

Mayberg

Wilson

Yatsu

. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis: Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991; 266: 3289–3294.

12.

Hobson

Weiss

Fields

. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis: The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993; 328: 221–227.

13.

Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273: 1421–1428.

14.

Moore

Barnett

HJM

Beebe

. Guidelines for carotid endarterectomy. Stroke. 1995; 26: 188–201.

15.

Ouriel

Hertzer

Beven

. Preprocedural risk stratification: Identifying an appropriate population for carotid stenting. J Vasc Surg. 2001; 33: 728–732.

16.

Veith

Amor

Ohki

. Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. J Vasc Surg. 2001; 33: S111–116.

17.

Ohki

Veith

Grenell

. Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg. 2002; 36: 1175–1185.

18.

Leger

Neale

Harris

. Poor durability of carotid angioplasty and stenting for treatment of recurrent artery stenosis after carotid endarterectomy: An institutional experience. J Vasc Surg. 2001; 33: 1008–1014.

19.

Shawl

. Carotid artery stenting: Acute and long-term results. Curr Opin Cardiol. 2002; 17: 671–676.

20.

Stankovic

Liistro

Moshiri

. Carotid artery stenting in the first 100 consecutive patients: Results and follow up. Heart. 2002; 88: 381–386.

21.

Ahmadi

Willfort

Lang

. Carotid artery stenting: Effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther. 2001; 8: 539–546.

22.

Criado

Lingelbach

Ledesma

. Carotid artery stenting in a vascular surgery practice. J Vasc Surg. 2002; 35: 430–434.

23.

Schillinger

Exner

Mlekusch

. Acute-phase response after stent implantation in the carotid artery: Association with 6-month in-stent restenosis. Radiology. 2003; 227: 516–521.

24.

New

Roubin

Iyer

. Safety, efficacy, and durability of carotid artery stenting for restenosis following carotid endarterectomy: A multicenter study. J Endovasc Ther. 2000; 7: 345–352.

25.

Wholey

Mathias

. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv. 2000; 50: 160–167.

26.

Willfort-Ehringer

Ahmadi

Gschwandtner

. Single-center experience with carotid stent restenosis. J Endovasc Ther. 2002; 9: 299–307.

27.

Brown

Desai

Schwartz

. Operative intervention for recurrent stenosis after carotid stent angioplasty: A report. Ann Vasc Surg. 2002; 16: 575–578.

28.

Hobson

Lal

Chakhtoura

. Carotid artery closure for endarterectomy does not influence results of angioplasty-stenting for restenosis. J Vasc Surg. 2002; 35: 435–438.

29.

AbuRahma

Bates

Stone

. Comparative study of operative treatment and percutaneous transluminal angioplasty/stenting for recurrent carotid disease. J Vasc Surg. 2001; 34: 831–838.

30.

AbuRahma

Bates

Wulu

. Early postsurgical carotid restenosis: Redo surgery versus angioplasty/stenting. J Endovasc Ther. 2002; 9: 566–572.

31.

Mintz

Popma

Hong

. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol. 1996; 78(Suppl 3A): 18–22.

32.

Bartlett

Rapp

Goldstone

. Recurrent carotid stenosis: Operative strategy and late results. J Vasc Surg. 1987; 5: 452–456.

33.

Das

Hertzer

Ratliff

. Recurrent carotid stenosis: A five-year series of 65 reoperations. Ann Surg. 1985; 202: 28–35.

34.

Treiman

Jenkins

Edwards

. The evolving surgical management of recurrent carotid stenosis. J Vasc Surg. 1992; 16: 354–363.

35.

Gruberg

Waksman

Ajani

. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol. 2002; 39: 1930–1936.

36.

Palmaz

Bailey

Marton

. Influence of stent design and material composition on procedure outcome. J Vasc Surg. 2002; 36: 1031–1039.